Arvinas Inc (NAS:ARVN)
$ 31.44 -0.51 (-1.6%) Market Cap: 2.15 Bil Enterprise Value: 984.80 Mil PE Ratio: 0 PB Ratio: 3.52 GF Score: 79/100

Arvinas Inc at Stifel Targeted Oncology Days (Virtual) Transcript

Apr 26, 2023 / 03:30PM GMT
Release Date Price: $27.13 (+0.41%)
Brad Canino
Stifel Financial Corp. - Analyst

All right. Thanks, everyone, for continuing to join us on the inaugural Stifel Targeted Oncology Days. My name is Brad Canino, senior analyst here at Stifel; delighted to host for a fireside chat Arvinas. We've got Ian Taylor, Chief Scientific Officer; and Sean Cassidy, Chief Financial Officer. So thank you both for [agreeing to stand and have a chat].

Sean Cassidy
Arvinas, Inc. - CFO & Treasurer

Yeah, thanks, Brad.

Ian Taylor
Arvinas, Inc. - Chief Scientific Officer

Thanks for having us.

Sean Cassidy
Arvinas, Inc. - CFO & Treasurer

Thanks for having us.

Questions & Answers

Brad Canino;Sean Cassidy
Stifel Financial Corp. - Analyst;

Yeah. And Sean, if I just could have you start out with a quick overview of the company, maybe status of the clinical oncology programs as well that we'll be discussing for the rest of the talk.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot